LAUREN HURST: Open Payments
NPI 1386425106 · COLUMBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Electromed, Inc. | 3 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: Korlym, CAPLYTA, GVOKE HYPOPEN, Kerendia, SMARTVEST, GEMTESA.
Industry payments across MS — which companies pay providers there.
